Search

Your search keyword '"Clarimon, Jordi"' showing total 534 results

Search Constraints

Start Over You searched for: Author "Clarimon, Jordi" Remove constraint Author: "Clarimon, Jordi"
534 results on '"Clarimon, Jordi"'

Search Results

1. Genome-wide analyses reveal a potential role for the MAPT, MOBP, and APOE loci in sporadic frontotemporal dementia.

2. A systematic review of progranulin concentrations in biofluids in over 7,000 people—assessing the pathogenicity of GRN mutations and other influencing factors

3. Genome-wide structural variant analysis identifies risk loci for non-Alzheimer’s dementias

4. Exome sequencing identifies rare damaging variants in ATP8B4 and ABCA1 as risk factors for Alzheimer’s disease

5. Genetic evaluation of dementia with Lewy bodies implicates distinct disease subgroups.

6. Sex differences in the behavioral variant of frontotemporal dementia: A new window to executive and behavioral reserve.

7. C9orf72, age at onset, and ancestry help discriminate behavioral from language variants in FTLD cohorts

8. Genome-wide structural variant analysis identifies risk loci for non-Alzheimer’s dementias

9. Prioritization of Drug Targets for Neurodegenerative Diseases by Integrating Genetic and Proteomic Data From Brain and Blood

10. New insights into the genetic etiology of Alzheimer’s disease and related dementias

11. Smoking is associated with age at disease onset in Parkinson's disease

12. A C6orf10/LOC101929163 locus is associated with age of onset in C9orf72 carriers.

13. Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture

14. Phosphorylated tau181 in plasma as a potential biomarker for Alzheimer’s disease in adults with Down syndrome

15. Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies

16. Genome-wide association analysis of dementia and its clinical endophenotypes reveal novel loci associated with Alzheimer's disease and three causality networks: The GR@ACE project

17. Longitudinal cerebrospinal fluid biomarker trajectories along the Alzheimer's disease continuum in the BIOMARKAPD study

18. The Sant Pau Initiative on Neurodegeneration (SPIN) cohort: A data set for biomarker discovery and validation in neurodegenerative disorders

19. Establishing an online resource to facilitate global collaboration and inclusion of underrepresented populations: Experience from the MJFF Global Genetic Parkinson’s Disease Project

20. Brain hypometabolism in non‐demented microtubule‐associated protein tau H1 carriers with Parkinson's disease

21. Plasma and CSF biomarkers for the diagnosis of Alzheimer's disease in adults with Down syndrome: a cross-sectional study

22. Cortical microstructural changes along the Alzheimer's disease continuum

23. Investigating the genetic architecture of dementia with Lewy bodies: a two-stage genome-wide association study

24. C9orf72, AAO and ancestry help discriminating behavioural from language variants in FTLD cohorts

25. Cerebral amyloid angiopathy in Down syndrome and sporadic and autosomal-dominant Alzheimer's disease

27. Genetic Associations Between Modifiable Risk Factors and Alzheimer Disease

28. Embracing Monogenic Parkinson's Disease: The MJFF Global Genetic PD Cohort

29. Genetic variation in APOE, GRN, and TP53 are phenotype modifiers in frontotemporal dementia

30. Embracing Monogenic Parkinson's Disease: The MJFF Global Genetic PD Cohort

31. Genetic Associations between Modifiable Risk Factors and Alzheimer Disease:[Inkl. correction]

32. Genome-wide structural variant analysis identifies risk loci for non-Alzheimer’s dementias

33. Multiancestry analysis of the HLA locus in Alzheimer's and Parkinson's diseases uncovers a shared adaptive immune response mediated by HLA-DRB1*04 subtypes

34. Establishing an online resource to facilitate global collaboration and inclusion of underrepresented populations:Experience from the MJFF Global Genetic Parkinson's Disease Project

35. Genetic Associations Between Modifiable Risk Factors and Alzheimer Disease

36. Brain hypometabolism in non-demented microtubule-associated protein tau H1 carriers with Parkinson's disease

37. Embracing Monogenic Parkinson's Disease: The MJFF Global Genetic PD Cohort

38. Establishing an online resource to facilitate global collaboration and inclusion of underrepresented populations: Experience from the MJFF Global Genetic Parkinson's Disease Project

39. Muscle imaging in muscle dystrophies produced by mutations in the EMD and LMNA genes

40. Role for ATXN1, ATXN2, and HTT intermediate repeats in frontotemporal dementia and Alzheimer's disease

42. GBA and APOE ε4 associate with sporadic dementia with Lewy bodies in European genome wide association study

44. Transethnic meta-analysis of rare coding variants in PLCG2, ABI3, and TREM2 supports their general contribution to Alzheimer’s disease

45. Relationship between cortical thickness and cerebrospinal fluid YKL-40 in predementia stages of Alzheimer's disease

46. Protective association of HLA‐DRB1*04 subtypes in neurodegenerative diseases implicates acetylated tau PHF6 sequences

47. Identification of a sex-specific genetic signature in dementia with Lewy bodies: a meta-analysis of genome-wide association studies

48. Deleterious ABCA7 mutations and transcript rescue mechanisms in early onset Alzheimer’s disease

49. A POGLUT1 mutation causes a muscular dystrophy with reduced Notch signaling and satellite cell loss

Catalog

Books, media, physical & digital resources